TY - JOUR
AU - Barrot H. Lambdin
AU - Ricky N. Bluthenthal
AU - Hansel E. Tookes
AU - Lynn Wenger
AU - Terry Morris
AU - Paul LaKosky
AU - Alex H. Kral
A1 - 
AD - RTI International, Berkeley, CA, US blambdin@rti.org; University of Southern California, Los Angeles, CA, US ; University of Miami, Miami, FL, US ; North American Syringe Exchange Network, Tacoma, WA, US ; Lambdin, Barrot H.,2150 Shattuck Avenue, Suite 800,Berkeley,US,94704,blambdin@rti.org
BT - Drug and Alcohol Dependence
C5 - Opioids & Substance Use ; HIT & Telehealth; Healthcare Policy
DB - APA PsycInfo®
DO - 10.1016/j.drugalcdep.2022.109504
JF - Drug and Alcohol Dependence
LA - English
PY - 2022
SN - 0376-8716, 0376-8716
SP - 1
EP - 5+
ST - Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States
T1 - Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States
T2 - Drug and Alcohol Dependence
TI - Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States
U1 - Opioids & Substance Use ; HIT & Telehealth; Healthcare Policy
U3 - 10.1016/j.drugalcdep.2022.109504
VL - 237
VO - 0376-8716, 0376-8716
Y1 - 2022
ER -